{
  "docId": "019de516-01ce-701d-bd9b-acac15fa9fab",
  "docSlug": "a13be9775a99db49a0c5c2ac3ee2ea88",
  "documentTitle": "Oculis | Investor Conference Presentation Deck | 39 slides",
  "authorId": "oculis",
  "authorName": "Oculis",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 23,
  "pageCount": 39,
  "prevPage": 22,
  "nextPage": 24,
  "slideType": "propose_solution",
  "function": "propose_solution",
  "density": "overcrowded",
  "nDataPoints": 1,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de516-01ce-701d-bd9b-acac15fa9fab/23",
  "deckHref": "/decks/019de516-01ce-701d-bd9b-acac15fa9fab",
  "deckJsonHref": "/decks/019de516-01ce-701d-bd9b-acac15fa9fab.json",
  "deckAnchorHref": "/decks/019de516-01ce-701d-bd9b-acac15fa9fab#slide-23",
  "components": [
    {
      "bbox": {
        "h": 0.04,
        "w": 0.12,
        "x": 0.85,
        "y": 0.04
      },
      "kind": "image",
      "text": "Oculis",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "691aa687-211c-4593-a932-122840901694",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.34,
        "w": 0.306,
        "x": 0.34,
        "y": 0.302
      },
      "kind": "list",
      "text": "Ophthalmologists\n+ Expand prescriber pool\n+ Provide versatility for retina specialist as standalone or combination with anti-VEGFs",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1cb4b106-2585-4389-87e4-1f20aef1605e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.34,
        "w": 0.306,
        "x": 0.65,
        "y": 0.302
      },
      "kind": "list",
      "text": "Payors\n+ Lower total cost with safe and efficacious solution\n+ Early intervention could result in reducing cost burden for payor system",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4fc912d0-7b7e-4421-9c7b-59471e8d2874",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.34,
        "w": 0.28,
        "x": 0.036,
        "y": 0.302
      },
      "kind": "list",
      "text": "DME Patients\n+ Positive benefits/risk\n+ Eye drops always preferred\n+ Benefits for working-age DME patients",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a16b347c-3720-4a65-9185-c5818438fafa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.94,
        "x": 0.026,
        "y": 0.12
      },
      "kind": "paragraph",
      "text": "Benefits highlighted in third-party market research performed independently with payers & physicians",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c4a458d3-f68c-4299-9156-2cb5b06637a2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.61,
        "x": 0.194,
        "y": 0.79
      },
      "kind": "paragraph",
      "text": "Current addressable US patient population: 1.2 million(1)(2)",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ff5fb972-9020-4f39-b59e-1ab04675840b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.44,
        "x": 0.036,
        "y": 0.915
      },
      "kind": "source-note",
      "text": "(1) Gonzalez 2016 Early and Long-term Responses to VEGF Therapy in DME: Analysis of protocol I data\n(2) Decision Resources Group: DME - DR Landscape Forecast - Disease Landscape Forecast 2020",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0850c0fd-c4a5-4413-971c-eaae005070d8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.076,
        "w": 0.79,
        "x": 0.026,
        "y": 0.04
      },
      "kind": "title",
      "text": "OCS-01 Offers Significant Potential to Improve Patient Outcomes, Expand Prescriber & Patient Pools and Reduce Costs for Payors",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4914266a-c953-4ea4-8625-a7d912403480",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "77b617af-bff4-462a-9780-925abb909689",
      "evidence": "The slide identifies the target audience for OCS-01, including payors, ophthalmologists, and patients.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 24,
      "from": 17,
      "beatId": "47165210-81f8-47ad-ae3f-2582e7380461",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Solution & Approach",
      "beatSlug": "consultants-gambit-solution-approach",
      "evidence": "Slides 17-24 outline OCS-01's potential and the Phase 3 program.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}